Harvard Bioscience, Inc. (HBIO)
NASDAQ · Healthcare
Harvard Bioscience, Inc. Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 86.5M | 94.1M | 112.3M | 113.3M | 118.9M | 102.1M | 116.2M | 120.8M | 77.4M | 104.5M | 108.7M | 108.7M | 105.2M | 111.2M | 108.9M | 108.2M | 85.8M |
| Gross Profit | 49.9M | 54.8M | 66.1M | 60.8M | 67.7M | 58.0M | 64.3M | 63.2M | 39.2M | 48.4M | 48.7M | 49.3M | 47.7M | 52.3M | 50.2M | 51.8M | 41.7M |
| Profitability | |||||||||||||||||
| Operating Income | -48.6M | -6.2M | 1.9M | -6.9M | 2.1M | 221,000 | 377,000 | 984,000 | -635,000 | -3.0M | -1.7M | 6.6M | 1.5M | 7.8M | 8.4M | 10.2M | 8.1M |
| EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | 12.0M | 12.7M | 14.1M | — |
| Net Income | -56.7M | -12.4M | -3.4M | -9.5M | -288,000 | -7.8M | -4.7M | -2.9M | -865,000 | -4.3M | -19.0M | 2.4M | -1.8M | 2.4M | 3.8M | 19.0M | 7.2M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 44M | 44M | 42M | 41M | 40M | 39M | 38M | 36M | 35M | 34M | 34M | 33M | 32M | 30M | 30M | 29M | 30M |
Harvard Bioscience, Inc. Income Statement — FAQ
Harvard Bioscience, Inc. (HBIO) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see HBIO's income statement history?
The chart and table above show Harvard Bioscience, Inc.'s income statement by year and by quarter, including the growth rate.